Clinical Implications of Isolated Bone Failure Without Systemic Disease Progression During EGFR-TKI Treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical Implications of Isolated Bone Failure Without Systemic Disease Progression During EGFR-TKI Treatment

Published:2016-11 Issue:6 Volume:17 Page:573-580.e1
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Hwang Ji An,Lee Ji Young,Kim Woo Sung,Song Joon Seon,Rho Jin Kyung,Choi Chang-Min,Lee Jae Cheol

Funder

National Research Foundation of Korea

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference36 articles.

1. Mechanisms of bone metastasis;Roodman;N Engl J Med,2004

2. Metastatic bone disease: clinical features, pathophysiology and treatment strategies;Coleman;Cancer Treat Rev,2001

3. Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: a randomized, phase III, double-blind, placebo-controlled trial;Rosen;Cancer,2004

4. Skeletal metastases in non-small cell lung cancer: a retrospective study;Tsuya;Lung Cancer,2007

5. Prospective study on the incidence of bone metastasis (BM) and skeletal-related events (SREs) in patients (pts) with stage IIIB and IV lung cancer-CSP-HOR 13;Katakami;J Thorac Oncol,2014

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inferior outcome of bone metastasis in non-small-cell-lung-cancer patients treated with epidermal growth factor receptor inhibitors;Journal of Bone Oncology;2021-08

2. Development of metastatic brain disease involves progression through lung metastases in EGFR mutated non-small cell lung cancer;Convergent Science Physical Oncology;2017-07-13

3. Epidermal growth factor receptor is associated with the onset of skeletal related events in non-small cell lung cancer;Oncotarget;2017-06-28

4. Microwave ablation combined with EGFR-TKIs versus only EGFR-TKIs in advanced NSCLC patients with EGFR-sensitive mutations;Oncotarget;2017-05-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3